Skip to main content

Advertisement

Log in

Status Epilepticus: An Update

  • Critical Care (SA Mayer, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Status epilepticus (SE) still results in significant mortality and morbidity. Whereas mortality depends mainly on the age of the patient as well as the cause, morbidity is often due to the myriad of complications that occur during prolonged admission to an intensive care environment. Although SE is a clinical diagnosis in most cases (convulsant), its treatment requires support by continuous electroencephalographic recording to ensure cessation of potential nonconvulsive elements of SE. Treatment has recently changed to incorporate four stages and must be initiated at the earliest possible time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Varelas PN, Mirski MA. Status epilepticus. Curr Neurol Neurosci Rep. 2009;9:469–76.

    Article  PubMed  Google Scholar 

  2. Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17:348–55.

    Article  PubMed  CAS  Google Scholar 

  3. •• Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23. These are latest guidelines from a large writing group representing the Neurocritical Care Society and using the GRADE system.

    Article  PubMed  Google Scholar 

  4. Gastaut H. Classification of status epilepticus. Adv Neurol. 1983;34:15–35.

    PubMed  CAS  Google Scholar 

  5. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on status epilepticus. JAMA. 1993;270:854–9.

    Google Scholar 

  6. Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia. 1999;40:120–2.

    Article  PubMed  CAS  Google Scholar 

  7. Jenssen S, Gracely EJ, Sperling MR. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia. 2006;47:1499–503.

    Article  PubMed  Google Scholar 

  8. Goodkin HP, Kapur J. Responsiveness of status epilepticus to treatment with diazepan decreases rapidly as seizure duration increases. Epilepsy Curr. 2003;3:11–2.

    Article  PubMed  Google Scholar 

  9. Lowenstein DH. The management of refractory status epilepticus: an update. Epilepsia. 2006;47 Suppl 1:35–40.

    Article  PubMed  Google Scholar 

  10. Shorvon S. What is nonconvulsive status epilepticus, and what are its subtypes? Epilepsia. 2007;48 Suppl 8:35–8.

    Article  PubMed  Google Scholar 

  11. Kaplan PW. Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol. 1999;16:341–52.

    Article  PubMed  CAS  Google Scholar 

  12. Walker MC. Diagnosis and treatment of nonconvulsive status epilepticus. CNS Drugs. 2001;15:931–9.

    Article  PubMed  CAS  Google Scholar 

  13. Kaplan PW. EEG criteria for nonconvulsive status epilepticus. Epilepsia. 2007;48 Suppl 8:39–41.

    Article  PubMed  Google Scholar 

  14. Sutter R, Kaplan PW. Electroencephalographic criteria for nonconvulsive status epilepticus: synopsis and comprehensive survey. Epilepsia. 2012;53 Suppl 3:1–51.

    Article  PubMed  Google Scholar 

  15. • Trinka E, Hofler J, Zerbs A. Causes of status epilepticus. Epilepsia. 2012;53 Suppl 4:127–38. This is a comprehensive review of the causes of SE.

    Article  PubMed  Google Scholar 

  16. Hauser WA. Status epilepticus: epidemiologic considerations. Neurology. 1990;40:9–13.

    PubMed  CAS  Google Scholar 

  17. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029–35.

    Article  PubMed  CAS  Google Scholar 

  18. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339:792–8.

    Article  PubMed  CAS  Google Scholar 

  19. Jordan KG. Nonconvulsive status epilepticus in acute brain injury. J Clin Neurophysiol. 1999;16:332–40. discussion 353.

    Article  PubMed  CAS  Google Scholar 

  20. Carrera E, Michel P, Despland PA, et al. Continuous assessment of electrical epileptic activity in acute stroke. Neurology. 2006;67:99–104.

    Article  PubMed  CAS  Google Scholar 

  21. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology. 2000;54:340–5.

    Article  PubMed  CAS  Google Scholar 

  22. Claassen J, Jette N, Chum F, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69:1356–65.

    Article  PubMed  CAS  Google Scholar 

  23. Claassen J, Peery S, Kreiter KT, et al. Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology. 2003;60:208–14.

    Article  PubMed  CAS  Google Scholar 

  24. Cocito L, Audenino D, Primavera A. Altered mental state and nonconvulsive status epilepticus in patients with cancer. Arch Neurol. 2001;58:1310.

    Article  PubMed  CAS  Google Scholar 

  25. Vespa PM, Nuwer MR, Nenov V, et al. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg. 1999;91:750–60.

    Article  PubMed  CAS  Google Scholar 

  26. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59:205–10.

    Article  PubMed  Google Scholar 

  27. Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005;76:534–9.

    Article  PubMed  CAS  Google Scholar 

  28. • Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51:251–6. This is a prospective study of RSE outcomes.

    Article  PubMed  Google Scholar 

  29. Wijdicks EF, Sharbrough FW. New-onset seizures in critically ill patients. Neurology. 1993;43:1042–4.

    Article  PubMed  CAS  Google Scholar 

  30. Bleck TP, Smith MC, Pierre-Louis SJ, Jares JJ, Murray J, Hansen CA. Neurologic complications of critical medical illnesses. Crit Care Med. 1993;21:98–103.

    Article  PubMed  CAS  Google Scholar 

  31. Drislane FW, Lopez MR, Blum AS, Schomer DL. Detection and treatment of refractory status epilepticus in the intensive care unit. J Clin Neurophysiol. 2008;25:181–6.

    Article  PubMed  Google Scholar 

  32. Bauer G, Trinka E. Nonconvulsive status epilepticus and coma. Epilepsia. 2010;51:177–90.

    Article  PubMed  Google Scholar 

  33. Tan RY, Neligan A, Shorvon SD. The uncommon causes of status epilepticus: a systematic review. Epilepsy Res. 2010;91:111–22.

    Article  PubMed  CAS  Google Scholar 

  34. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med. 1998;338:970–6.

    Article  PubMed  CAS  Google Scholar 

  35. Millikan D, Rice B, Silbergleit R. Emergency treatment of status epilepticus: current thinking. Emerg Med Clin North Am. 2009;27:101–1.

    Article  PubMed  Google Scholar 

  36. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia. 2000;41 Suppl 2:S23–30.

    Article  PubMed  Google Scholar 

  37. Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. 1980;69:657–66.

    Article  PubMed  CAS  Google Scholar 

  38. Loscher W. Mechanisms of drug resistance in status epilepticus. Epilepsia. 2007;48 Suppl 8:74–7.

    Article  PubMed  Google Scholar 

  39. Bankstahl JP, Loscher W. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus. Epilepsy Res. 2008;82:70–85.

    Article  PubMed  CAS  Google Scholar 

  40. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. 1998;39:833–40.

    Article  PubMed  CAS  Google Scholar 

  41. Brenner RP. Is it status? Epilepsia. 2002;43 Suppl 3:103–13.

    Article  PubMed  Google Scholar 

  42. Kaplan PW. The EEG of status epilepticus. J Clin Neurophysiol. 2006;23:221–9.

    Article  PubMed  Google Scholar 

  43. Pedersen GL, Rasmussen SB, Gyllenborg J, Benedek K, Lauritzen M. Prognostic value of periodic electroencephalographic discharges for neurological patients with profound disturbances of consciousness. Clin Neurophysiol. 2013;124:44–51.

    Article  PubMed  Google Scholar 

  44. • Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011;69:892–900. This is an important article describing a new seizure entity with important implications.

    Article  PubMed  Google Scholar 

  45. Irani SR, Vincent A, Schott JM. Autoimmune encephalitis. BMJ. 2011;342:d1918.

    Article  PubMed  Google Scholar 

  46. Varelas PN, Spanaki MV. Management of status epilepticus and critical care seizures. In: Varelas PN, editor. Seizures in critical care. A guide to diagnosis and treatment. New York: Humana; 2010. p. 355–422.

    Chapter  Google Scholar 

  47. Cook AM, Castle A, Green A, et al. Practice variations in the management of status epilepticus. Neurocrit Care. 2012;17:24–30.

    Article  PubMed  Google Scholar 

  48. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345:631–7.

    Article  PubMed  CAS  Google Scholar 

  49. Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366:591–600.

    Article  PubMed  CAS  Google Scholar 

  50. •• Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:2802–18. This is a comprehensive review of treatments available for SE.

    Article  PubMed  Google Scholar 

  51. Shorvon S, Ferlisi M. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012;135:2314–28.

    Article  PubMed  Google Scholar 

  52. McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366:205–10.

    Article  PubMed  CAS  Google Scholar 

  53. Misra UK, Kalita J, Maurya PK. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J Neurol. 2012;259:645–8.

    Article  PubMed  CAS  Google Scholar 

  54. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure. 2007;16:527–32.

    Article  PubMed  Google Scholar 

  55. Zelano J, Kumlien E. Levetiracetam as alternative stage two antiepileptic drug in status epilepticus: a systematic review. Seizure. 2012;21:233–6.

    Article  PubMed  Google Scholar 

  56. Trinka E. What is the evidence to use new intravenous AEDs in status epilepticus? Epilepsia. 2011;52 Suppl 8:35–8.

    Article  PubMed  CAS  Google Scholar 

  57. Alvarez V, Januel JM, Burnand B, Rossetti AO. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia. 2011;52:1292–6.

    Article  PubMed  CAS  Google Scholar 

  58. Hofler J, Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia. 2013;

  59. Towne AR, Garnett LK, Waterhouse EJ, Morton LD, DeLorenzo RJ. The use of topiramate in refractory status epilepticus. Neurology. 2003;60:332–4.

    Article  PubMed  CAS  Google Scholar 

  60. Hottinger A, Sutter R, Marsch S, Ruegg S. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study. CNS Drugs. 2012;26:761–72.

    Article  PubMed  CAS  Google Scholar 

  61. Swisher CB, Doreswamy M, Gingrich KJ, Vredenburgh JJ, Kolls BJ. Phenytoin, levetiracetam, and pregabalin in the acute management of refractory status epilepticus in patients with brain tumors. Neurocrit Care. 2012;16:109–13.

    Article  PubMed  CAS  Google Scholar 

  62. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146–53.

    Article  PubMed  CAS  Google Scholar 

  63. Krishnamurthy KB, Drislane FW. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia. 1999;40:759–62.

    Article  PubMed  CAS  Google Scholar 

  64. Treiman DM. Convulsive status epilepticus. Curr Treat Options Neurol. 1999;1:359–69.

    Article  PubMed  Google Scholar 

  65. Krishnamurthy KB, Drislane FW. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia. 1996;37:863–7.

    Article  PubMed  CAS  Google Scholar 

  66. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62:1698–702.

    Article  PubMed  Google Scholar 

  67. Kramer AH. Early ketamine to treat refractory status epilepticus. Neurocrit Care. 2012;16:299–305.

    Article  PubMed  Google Scholar 

  68. Synowiec AS, Singh DS, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM. Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res. 2013. doi:10.1016/j.eplepsyres.2013.01.007.

    PubMed  Google Scholar 

  69. Schulze-Bonhage A, Kurthen M, Walger P, Elger CE. Pharmacorefractory status epilepticus due to low vitamin B6 levels during pregnancy. Epilepsia. 2004;45:81–4.

    Article  PubMed  Google Scholar 

  70. Kluger G, Blank R, Paul K, et al. Pyridoxine-dependent epilepsy: normal outcome in a patient with late diagnosis after prolonged status epilepticus causing cortical blindness. Neuropediatrics. 2008;39:276–9.

    Article  PubMed  CAS  Google Scholar 

  71. Minns AB, Ghafouri N, Clark RF. Isoniazid-induced status epilepticus in a pediatric patient after inadequate pyridoxine therapy. Pediatr Emerg Care. 2010;26:380–1.

    Article  PubMed  Google Scholar 

  72. Visser NA, Braun KP, Leijten FS, van Nieuwenhuizen O, Wokke JH, van den Bergh WM. Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. J Neurol. 2011;258:218–22.

    Article  PubMed  CAS  Google Scholar 

  73. Iannetti P, Spalice A, Parisi P. Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus. Epilepsia. 2005;46:967–9.

    Article  PubMed  Google Scholar 

  74. Iannetti P, Parisi P, Spalice A, Ruggieri M, Zara F. Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy. Epilepsy Res. 2009;85:89–95.

    Article  PubMed  CAS  Google Scholar 

  75. Corry JJ, Dhar R, Murphy T, Diringer MN. Hypothermia for refractory status epilepticus. Neurocrit Care. 2008;9:189–97.

    Article  PubMed  CAS  Google Scholar 

  76. Rossetti AO. What is the value of hypothermia in acute neurologic diseases and status epilepticus? Epilepsia. 2011;52 Suppl 8:64–6.

    Article  PubMed  Google Scholar 

  77. Sierra-Marcos A, Maestro I, Rodriguez-Osorio X, et al. Successful outcome of episodes of status epilepticus after vagus nerve stimulation: a multicenter study. Eur J Neurol. 2012;19:1219–23.

    Article  PubMed  CAS  Google Scholar 

  78. Walker MC. The potential of brain stimulation in status epilepticus. Epilepsia. 2011;52 Suppl 8:61–3.

    Article  PubMed  Google Scholar 

  79. Lambrecq V, Villega F, Marchal C, et al. Refractory status epilepticus: electroconvulsive therapy as a possible therapeutic strategy. Seizure. 2012;21:661–4.

    Article  PubMed  Google Scholar 

  80. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia. 1994;35:27–34.

    Article  PubMed  CAS  Google Scholar 

  81. DeLorenzo RJ, Towne AR, Pellock JM, Ko D. Status epilepticus in children, adults, and the elderly. Epilepsia. 1992;33 Suppl 4:S15–25.

    Article  PubMed  Google Scholar 

  82. Legriel S, Mourvillier B, Bele N, et al. Outcomes in 140 critically ill patients with status epilepticus. Intensive Care Med. 2008;34:476–80.

    Article  PubMed  Google Scholar 

  83. Rossetti AO, Oddo M, Liaudet L, Kaplan PW. Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology. 2009;72:744–9.

    Article  PubMed  Google Scholar 

  84. Hocker SE, Britton JW, Mandrekar JN, Wijdicks EF, Rabinstein AA. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2013;70:72–7.

    Article  PubMed  Google Scholar 

  85. Rossetti AO, Logroscino G, Bromfield EB. A clinical score for prognosis of status epilepticus in adults. Neurology. 2006;66:1736–8.

    Article  PubMed  Google Scholar 

  86. Rossetti AO, Logroscino G, Milligan TA, Michaelides C, Ruffieux C, Bromfield EB. Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol. 2008;255:1561–6.

    Article  PubMed  Google Scholar 

  87. Hesdorffer DC, Logroscino G, Cascino GD, Hauser WA. Recurrence of afebrile status epilepticus in a population-based study in Rochester, Minnesota. Neurology. 2007;69:73–8.

    Article  PubMed  CAS  Google Scholar 

  88. Varelas PN, Mirski MA. Seizures in the adult intensive care unit. J Neurosurg Anesthesiol. 2001;13:163–75.

    Article  PubMed  CAS  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Panayiotis N. Varelas declares no conflict of interest.

Marianna V. Spanaki declares no conflict of interest.

Marek A. Mirski declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Panayiotis N. Varelas.

Additional information

This article is part of the Topical Collection on Critical Care

Rights and permissions

Reprints and permissions

About this article

Cite this article

Varelas, P.N., Spanaki, M.V. & Mirski, M.A. Status Epilepticus: An Update. Curr Neurol Neurosci Rep 13, 357 (2013). https://doi.org/10.1007/s11910-013-0357-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11910-013-0357-0

Keywords

Navigation